ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 60.00
-0.80 (-1.32%)
Jan 21, 2026, 2:17 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 3.7 billion as of January 21, 2026. Its market cap has increased by 134.04% in one year.
Market Cap
3.70B
Enterprise Value
3.26B
Revenue
36.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
60.00
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 1.38B to 3.70B, an increase of 168.36%. That is a compound annual growth rate of 24.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.70B | -8.33% |
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.98M | -31.96% |
| Jul 27, 2021 | 1.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senhwa Biosciences | 4.10B |
| Energenesis Biomedical CO.,LTD. | 4.02B |
| BRIM Biotechnology | 3.79B |
| Intech Biopharm | 3.76B |
| 3D Global Biotech | 3.59B |
| Genovate Biotechnology | 3.45B |
| Shine-On BioMedical | 3.42B |
| Syngen Biotech | 3.37B |